Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2026-02-20 @ 1:33 PM
Study NCT ID:
NCT00110695
Status:
COMPLETED
Last Update Posted:
2010-03-26
First Post:
2005-05-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2006-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-05-12
First Submit QC Date:
None
Study First Post Date:
2005-05-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-03-24
Last Update Post Date:
2010-03-26
Last Update Post Date Type:
ESTIMATED